Calvin W. Roberts, M.D., is corporate vice president and chief medical officer of Bausch + Lomb. He was named to this post in March 2011.
Dr. Roberts coordinates our global D&R efforts across our Vision Care, Pharmaceuticals and Surgical business units for optimal leverage and outcomes.
An expert and innovator in ophthalmic medical products and cataract surgery, Dr. Roberts has a unique blend of academic, clinical, business and hands-on product development experience. He has led the development and commercialization of numerous OTC and prescription pharmaceuticals, and is a frequent industry lecturer and author.
In 2003, Dr. Roberts co-founded Alimera Sciences, Inc., the specialty pharmaceuticals company.
Dr. Roberts holds patents on the wide-field specular microscope, used for corneal endothelial studies, and is the developer of instruments for cataract surgery. As a consultant to ophthalmic pharmaceutical companies, including Allergan Pharmaceuticals, Johnson & Johnson and Novartis, Roberts has helped lead the development and marketing efforts for several new therapeutics.
He is a clinical professor of ophthalmology at the Weill Medical College of Cornell University. As a practicing ophthalmologist from 1998 to 2008, he performed more than 10,000 cataract surgeries plus 5,000 refractive and other corneal surgeries.
A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at Columbia Presbyterian Hospital in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.